Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00707837 · ClinicalTrials.gov registry record · Phase 3
Nutritional Study in Preterm Infants
A Phase 3 study of Preterm Infants, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 206
- Enrollment target
- 8
- Study locations
NCT00707837: Completed Phase 3 study of Preterm Infants, sponsored by Abbott Nutrition.
NCT00707837 is a Phase 3 study of Preterm Infants that has completed, run by Abbott Nutrition. The registered enrollment target is 206 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00707837, a Phase 3 study of Preterm Infants, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 206 participants
- Enrollment target
- 8
- Study locations
Study Summary
An evaluation of a preterm infant formula containing ingredients similar to those found in breastmilk
Conditions Studied
Interventions
- OTHER Preterm infant formulas and discharge formulas
- OTHER Preterm infant formula with added soluble lipids
Study Locations (8)
Florida
- West Coast Neonatalogy, All Children's Hospital - St. Petersburg
- University of South Florida - Tampa
Alabama
- University of Alabama - Birmingham
Kentucky
- University of Louisville - Louisville
New York
- Maria Fareri Children's Hospital at Winchester Medical Center - Vahalla
Ohio
- MetroHealth Medical Center - Cleveland
Rhode Island
- Women & Infants Hospital of Rhode Island - Providence
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
What the finished NCT00707837 record still lists
NCT00707837 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Preterm Infants appearing as the primary indexed condition, and to 2 interventions - of which Preterm infant formulas and discharge formulas is the first listed.
NCT00707837 lists 8 locations in 7 states (Florida, Alabama, Kentucky).
Frequently Asked Questions
What is clinical trial NCT00707837 about?
NCT00707837 is a clinical study titled "Nutritional Study in Preterm Infants". An evaluation of a preterm infant formula containing ingredients similar to those found in breastmilk
What is the current status of trial NCT00707837?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 206 participants. The study started on 2005-05. Estimated completion is 2008-08.
What conditions does trial NCT00707837 study?
This clinical trial studies the following conditions: Preterm Infants.
What interventions are being tested in trial NCT00707837?
The interventions under investigation include: Preterm infant formulas and discharge formulas (OTHER), Preterm infant formula with added soluble lipids (OTHER).
Who is sponsoring clinical trial NCT00707837?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00707837 being conducted?
This trial has 8 study locations across Alabama, Florida, Kentucky, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Infants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00707837's enrollment target sits among peer trials
206 1347th of 2000 higher than 651 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia